| 1 |
dpavlin |
1.1 |
#Year Text 1 Text 2 Text 3 Text 4 Text 5 |
| 2 |
|
|
1 1921 in Karlovac, companies "Chinoin" from Budapest and "Isis" from Zagreb found "Kaptel" d.d., the predecessor of today's PLIVA |
| 3 |
|
|
5 1935 organised research starts in "Kaptel" with the arrival of Nobel Prize winner dr. Vladimir Prelog |
| 4 |
|
|
10 1936 "Kaptel" d.d. becomes one of the first producers of sulphonamides in the world |
| 5 |
|
|
15 1952 PLIVA Research Institute was founded |
| 6 |
|
|
20 1953 the first production of Vitamin C using its own technology |
| 7 |
|
|
25 1959 oxytetracycline and Vitamin B6 production starts |
| 8 |
|
|
30 1971 metacycline patented |
| 9 |
|
|
35 1980 PLIVA's own original macrolide antibiotic patented - called azithromycin, which lists Croatia among the 9 countries world-wide that have their own antibiotic substance |
| 10 |
|
|
40 1986 PLIVA signs azithromycin license agreement with "Pfizer", according to which PFIZER gets exclusive sales rights for US and Western Europe |
| 11 |
|
|
45 1988 azithromycin launched under brand name SUMAMED |
| 12 |
|
|
50 1991 PFIZER launches azithromycin under brand name ZITHROMAX |
| 13 |
|
|
55 1996 listing of PLIVA's shares on London and Zagreb Stock Exchange |
| 14 |
|
|
60 1997 acquisition of PLIVA Krakow |
| 15 |
|
|
65 1998 new azithromycin production facility was open |
| 16 |
|
|
70 1999 acquisition of FARMACOM acquisition of MIXIS GENETICS Ltd. |
| 17 |
|
|
75 1999 acquisition of LACHEMA |
| 18 |
|
|
80 2000 acquisition of Dominion |
Parent Directory
| 
Revision Log